Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

Erythrocytes or red blood cells (RBCs) represent a promising cell-mediated drug delivery platform due to their inherent biocompatibility. Here, we developed an antigen delivery system based on the nanoerythrosomes derived from RBCs, inspired by the splenic antigen-presenting cell targeting capacity...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiao, Shen, Shufang, Fan, Qin, Chen, Guojun, Archibong, Edikan, Dotti, Gianpietro, Liu, Zhuang, Gu, Zhen, Wang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810293/
https://www.ncbi.nlm.nih.gov/pubmed/31681841
http://dx.doi.org/10.1126/sciadv.aaw6870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810293/
https://www.ncbi.nlm.nih.gov/pubmed/31681841
http://dx.doi.org/10.1126/sciadv.aaw6870

Ejemplares similares